arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

BioAtla, Inc.

BCAB Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.31
▲ +0.8% Today
as of Oct 2, 16:46 ET
Last 30 days -58.01% Aug 26 → Oct 02
$0.92 $1.51 $2.11 $2.71 $3.30 Aug 26 Sep 02 Sep 10 Sep 18 Sep 25 Oct 02
Open
$1.23
High
$1.65
Low
$1.23
Volume
$2,312
Avg Vol
$49,637
Mkt Cap
$6M
P/E (TTM)
—
Beta
—
52w High
$71.50
52w Low
$1.07
Div Yield
—
Shares Out
$2M

BCAB earnings at a glance

Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±5.3% on average; after the most recent report on May 15, 2026 it moved -2.3%. BCAB beat the consensus EPS estimate in 0 of its last 2 reported quarters. The share price of $1.31 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.07
$72
0% of range
Avg surprise (last 2)
-5.2%
Avg reaction (last 2)
-5.3%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.18$-4.57$-2.96$-1.34$0.27 Actual $-0.58Actual $-0.75Actual $-0.70Actual $-0.48Actual $-0.44Actual $-0.22Actual $-0.29Est $-0.28Actual $-0.31Est $-0.29Actual $-0.27Actual $-6.18Actual $0.27 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-19M$-14M$-9M$-4M$474,600 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.27 — — — — financials
Fri May 15, 2026Mar/2026 $-6.18 — — -2,031% -2.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.27 — — — — financials
Thu Aug 7, 2025Jun/2025 $-0.31 $-0.29 -6.9% — — earnings
Tue May 6, 2025Mar/2025 $-0.29 $-0.28 -3.6% — -8.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.22 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.44 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.48 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.70 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.75 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.58 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$227,000$-9M—$-14M$-19M$-18M—$-11M
Net income$452,000$-6M—$-16M$-19M$-15M—$-11M
EPS (diluted)$0.27$-4.22—$-0.27$-15.99$-13.16—$-0.22

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2M$2M$7M$8M$18M$32M$49M$57M
Inventory————————
Total current assets$4M$3M$8M$10M$21M$38M$51M$61M
Total assets$10M$9M$14M$16M$27M$38M$52M$62M
Long-term debt————————
Total liabilities$46M$46M$50M$47M$44M$38M$38M$39M
Total equity$-36M$-37M$-36M$-31M$-17M$547,000$14M$23M

Implied volatility — last 90 days

No IV snapshots yet for BCAB.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

BCAB earnings FAQ

How does BCAB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.3%, up 0 times and down 2 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.